Skip to main content
. Author manuscript; available in PMC: 2016 Nov 1.
Published in final edited form as: J Cardiovasc Transl Res. 2015 Jul 21;8(8):475–483. doi: 10.1007/s12265-015-9644-2

Table 3.

Characteristics of Mayo Clinic Primary Care Internal Medicine Practice

Characteristics Definite HF cases
with reduced EF
Definite HF cases
with preserved EF
Definite HF cases
(unknown type)
Probable HF
cases with
reduced EF
Probable HF
cases with
preserved EF
Probable HF case
(unknown type)
Possible HF
cases
Non-cases
n 760 754 391 422 497 494 3,668 72,663
Sex, % female 39 61 53 35 62 57 50 56
Race, % white 93 92 94 96 96 96 93 80
Diabetes, % yes 45 48 48 42 46 43 34 12
Hypertension, % yes 92 95 96 93 97 95 86 31
ICD-9 Code 428, % yes 100 100 100 99 99 99 62 0
ICD-9 Code 428 unique dates, mean ± SD (range)* 19 ± 20 (1–165) 15 ± 17 (1–159) 16 ± 19 (1–189) 20 ± 19 (1–144) 15 ± 14 (1–97) 15 ± 13 (1–91) 2.0 ± 1.2 (1–10) n/a
NLP HF term, % yes 100 100 100 7.6 7.7 5.1 12 0
NLP HF term unique dates, mean ± SD (range)* 12 ± 17 (1–200) 6.6 ± 8.6 (1–67) 8.8 ± 15 (1–154) 2.4 ± 2.6 (1–11) 2.0 ± 2.2 (1–12) 2.4 ± 2.1 (1–8) 1.4 ± 0.9 (1–8) n/a
EF measured, % yes 100 100 80 100 99 70 87 21
EF measurement unique dates, mean ± SD (range)* 15 ± 13 (1–132) 11 ± 9.5 (1–131) 7.3 ± 7.0 (1–63) 12 ± 11 (1–87) 9.1 ± 7.1 (1–54) 5.7 ± 5.3 (1–48) 7.1 ± 6.3 (1–52) 4.1 ± 3.7 (1–54)
EF, mean ± SD 42 ± 16 59 ± 9.6 51 ± 15 40 ± 15 59 ± 10 51 ± 15 54 ± 12 61 ± 6.2
History of myocardial infarction, % yes 88 76 80 91 82 82 65 12
Medication history
  Angiotensin converting enzyme use, % yes 79 69 73 83 70 67 55 14
  Angiotensin receptor blocker use, % yes 20 26 17 21 23 16 12 3
  Beta blocker use, % yes 80 73 69 76 69 60 58 16
  Calcium channel blocker use, % yes 39 48 39 39 53 42 31 7

EF ejection fraction, HF heart failure, ICD-9 International Classification of Diseases, 9th Revision, NLP natural language processing, SD standard deviation

*

For those with non-missing data